findmyKOL
Clinical trialNCT01035502CompletedPhase 2Interventional

A Study of Elacytarabine (CP-4055) Plus Idarubicin as Second Course Remission-Induction Therapy in Patients With Acute Myeloid Leukaemia

SponsorClavis PharmaEnrollment51Acute Myeloid Leukemia
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

France
  • Chu Lyon, Hospital Edouard Herriot

    Lyon, France

  • Institut Paoli-Calmettes

    Marseille, France

  • Chu Toulouse, Hospital Purpan

    Toulouse, France

Germany
  • Charite University Hospital Benjamin Franklin

    Berlin, Germany

  • Universitätsklinikum Münster

    Münster, Germany

  • Universitätsklinikum Ulm

    Ulm, Germany

Norway
  • Haukeland University Hospital

    Bergen, Norway

United States
  • Duke University Medical Center

    Durham, North Carolina, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Dec 2009
Primary completion
31 May 2013
Completion
30 Jun 2013
Last update posted
27 Sept 2013
Registered enrollment
51
Registry id
NCT01035502
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.